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Progressive multifocal leukoencephalopathy is a fatal
demyelinating disorder caused by JC virus infection. JC
virus was recently found to target promyelocytic leuke-
mia nuclear bodies (PML-NBs), punctuate domains in
the nuclei. Thus, the virus progenies cluster in dots as
intranuclear inclusions (ie, as dot-shaped inclusions).
In the present study, both the viral major and minor
capsid proteins were expressed from polycistronic ex-
pression vectors with a powerful promoter, and forma-
tion into virus-like particles (VLPs) was examined by
electronmicroscopy. When the upstream regulatory se-
quence including the agnogene (nt 275 to 490) was pres-
ent, capsid protein expression was suppressed, but nu-
merous VLPs were efficiently formed with restricted
accumulation to PML-NBs. VLPs were uniform, and the
cells were severely degraded. In contrast, when the 5=
terminus of the agnogene (nt 275 to 409; 135 bp) was
deleted, capsid protein expression was markedly en-
hanced, but VLPs were more randomly produced in the
nucleus outside of PML-NBs. VLPs were pleomorphic,
and cell degradation was minimal. JC virus association
with PML-NBs was confirmed in human brain tissues by
structured illumination microscopy. PML-NBs were
shaped in spherical shells, with viral capsid proteins
circumscribing the surface. These findings indicate
that PML-NBs are intranuclear locations for patho-
genic JC virus proliferation. Either the agnogene or its
product likely supports efficient progeny production
at PML-NBs, leading to subsequent degeneration ofhost glial cells. (Am J Pathol 2012, 180:1095–1106; DOI:
10.1016/j.ajpath.2011.11.036)
Progressive multifocal leukoencephalopathy is a fatal de-
myelinating disorder that develops on JC virus reactiva-
tion due to impaired immunity. Interest in this disease has
increased recently in relation to the use of monoclonal
antibodies as immunomodulatory drugs for treatment of
multiple sclerosis, malignant lymphoma, and Crohn’s dis-
ease.1–5 When the immune system is suppressed, JC
virus can reactivate and proliferate in the nucleus of oli-
godendrocytes, leading to destruction of the myelin
sheath. Classical neuropathological observations have
demonstrated that oligodendroglia harbor amphophilic
viral inclusions in the entire volume of enlarged nuclei, as
visualized by H&E staining (full inclusions). Indeed, this
finding has been a diagnostic hallmark of the disease.6
With use of immunohistochemistry or in situ hybridization,
however, recent studies have revealed that viral inclu-
sions in dots are also present frequently beneath the
nuclear membrane (dot-shaped inclusions).6,7 The dot-
shaped inclusions represent accumulation of progeny
viruses at distinct subnuclear domains called promyelo-
cytic leukemia nuclear bodies (PML-NBs; note that “PML”
refers herein only to promyelocytic leukemia, or PML pro-
tein, and not to the demyelinating disease).
In the process of viral replication cycle, the viral major
and minor capsid proteins cooperatively accumulate to
PML-NBs, where they are assembled into progeny viri-
ons.8,9 The progenies may later disperse from PML-NBs
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therefore, indicative of an early stage of viral infection
before full-inclusion development and so are potentially
useful for early diagnosis. Similar observation was al-
ready made via electron microscopy some three de-
cades ago; in the early stage of viral infection, JC virus
progeny, round or filamentous structures are always de-
tectable near the inner nuclear membrane.10 Neverthe-
less, although the intranuclear location of progeny pro-
duction appears to be important for pathogenesis of the
disease, to date few studies have focused on this aspect.
PML-NBs are subnuclear spherical structures, ubiqui-
tously present in eukaryotic nuclei.11,12 In dividing cells,
the size and the number of PML-NBs dynamically alter
with normal cell cycling,13–16 and, in response to a variety
of stresses, the PML-NB spheres usually enlarge.11 Mul-
tiple roles of PML-NBs include transcription, DNA repli-
cation and repair, telomere lengthening, chromatin orga-
nization, cell cycle control, apoptosis, tumor suppression,
and antiviral response, as described in a number of re-
views.11,17–19 PML-NBs are macromolecular structures
with essential components of PML and Sp100. To date,
approximately 80 nuclear proteins (a number that is still
increasing), including p53, CBP/p300, Daxx, BLM, Pin1,
HDAC7, and pRB, have been reported to reside in or to
be released from PML-NBs, depending on cellular con-
ditions. Pathological relevance of PML-NBs first arose
with acute promyelocytic leukemia, in which PML-NBs
disappear with fusion of the PML gene because of chro-
mosomal translocation t(15;17).20–23 Today, it is known
that expression of the PML protein, a p53 cooperating
tumor suppressor, is also lost or decreased in a variety of
human malignant tumors, including cancers originating
from prostate, lung, breast, and colon, as well as lympho-
mas, central nervous system tumors, and germ cell tu-
mors.24 Of note, PML-NBs are also related to neurode-
generative disorders such as Huntington’s disease or
spinocerebellar ataxias, which are characterized by the
presence of intranuclear inclusions in neuronal cells.25–27
Moreover, many DNA viruses, including herpes simplex
virus 1 (HSV-1), human cytomegalovirus (HCMV), Ep-
stein-Barr virus (EBV; HHV-4), papillomaviruses, and
polyomaviruses, target the PML-NBs and proliferate in
the nucleus to form intranuclear vial inclusions.28–31
Here, our interest is in the pathological roles of PML-
NBs in progressive multifocal leukoencephalopathy, a JC
virus-induced demyelinating disease. Although JC virus
was found to target PML-NBs in human glial cells, the
mechanism and implication of PML-NB pathology is not
fully understood. We therefore examined intranuclear
sites for JC virus progeny production by electron micros-
copy and structured illumination microscopy (SIM). The
viral major and minor capsid proteins were expressed
under the powerful SR promoter,32 a chimeric promoter
of SV40 and human T-cell leukemia virus type 1 (HTLV-1),
and formation into virus-like particles (VLPs)8,9 was ex-
amined in COS-7 cells. Our model system overcame the
difficulty of slow replication of the JC virus in cell culture
systems. Using this system, we previously identified that
PML-NBs, ubiquitous intranuclear domains in eukaryotic
cells, are the target of JC virus infection. Our system alsoenables electron microscopic analysis with colloidal gold
labeling, because morphology of VLP-harboring cells are
relatively well preserved. Intranuclear VP1 distribution and
capsid assembly were therefore further examined in the
presence or absence of the agnogene by immunoelectron
microscopy. Importance of the intranuclear locations of
progeny production was also confirmed in oligodendroglia
with natural viral infection, obtained from autopsied human
brain tissues. A novel super-resolution SIM33 revealed the
precise intranuclear locations for JC virus proliferation.
Materials and Methods
Plasmids
JC virus Tokyo-1 strain (GenBank accession number
AF030085) was used to construct expression vectors as
described previously.8,34 Construction of WT/AVP231
and DL-Mt/VP231 (previously known as AVP231-SR and
VP231-SR, respectively) is described in detail else-
where.8,34 Briefly, polycistronic genomic fragments of JC
virus Tokyo-1 strain were ligated downstream of the pow-
erful SR promoter,32 a chimera of a SV40 promoter-
enhancer unit and long terminal repeat (LTP) of human
T-cell leukemia virus type 1 (HTLV-1). The resulting plas-
mid vector, WT/AVP231, contains a viral genome frag-
ment corresponding to nucleotides (nt) 275 to 2531 of JC
virus Tokyo-1 strain, which includes the coding sequences
of the agnoprotein (71 amino acids, nt 275 to 490), VP2 (344
amino acids, nt 524 to 1558), VP3 (225 amino acids, nt 881
to 1558), and VP1 (354 amino acids, 1467 to 2531). The
vector DL-Mt/VP231 contains a genomic fragment corre-
sponding to nucleotides 410 to 2531, which includes
the coding sequences of VP2, VP3, and VP1, but lacks
the partial sequence of the agnogene (nt 275 to 409; 135
bp; this sequence includes the ATG start codon). The
coding sequence of VP1 (ie, nt 1467 to 2531 of the viral
genome) was also inserted into the vector to study the
effects of VP1 expression in the absence of expression of
VP2 and VP3. WT/AVP231 and DL-Mt/VP231 are unique,
because the vector-derived RNAs contain more than one
open reading frame (ORF). It has been demonstrated
previously that the vector-derived RNAs are alternatively
spliced in use of the viral authentic splice sites, and thus
major and minor capsid proteins are expressed in an
appropriate ratio.8,9 Assembly of VLPs was also con-
firmed by electron microscopy.8,34
Transfection
For transfection, COS-7 cells were incubated at 37°C and
5% CO2 in Dulbecco’s modified Eagle’s minimum essen-
tial medium supplemented with 10% fetal bovine serum.
The cells were then transfected with either WT/AVP231 or
DL-Mt/VP231 in use of Lipofectamine (Gibco BRL; Invit-
rogen, Carlsbad, CA), and harvested 72 hours after
transfection. The equal transfection and plasmid DNA
replication efficiency was analyzed by extracting DNA
from cells transfected with WT/AVP231 or from those
transfected with DL-Mt/VP231. The DNA extracts were
serially diluted from 1:1 to 1:1000, and then analyzed by
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tions for the V1 primer are nt 429 to 448 in the sense
strand, and for the VAS8 primer they are nt 815 to 796 in
the anti-sense strand. The PCR products were then semi-
quantitatively compared.
Immunoblotting
The transfected COS-7 cells were homogenized in so-
dium dodecyl sulfate sample buffer and reduced by boil-
ing at 95°C for 5 minutes. The protein was separated by
electrophoresis on 12.5% sodium dodecyl sulfate poly-
acrylamide gels and transferred to a nitrocellulose mem-
brane in 50 mmol/L Tris buffer containing 145 mmol/L
glycine. The membrane was blocked for 60 minutes at
room temperature with 5% nonfat milk and then reactedwith
the anti-VP1BC antibody.8,34 Peroxidase-labeled anti-rabbit
IgG was used as the secondary antibody. A Western Light-
ning Chemiluminescence Reagent Plus kit (PerkinElmer
LAS, Boston, MA) was used for detection.
Conventional Laser Scanning Confocal
Microscopy
For conventional laser scanning confocal microscopy
(LSCM), cells were cultured on tissue culture glass slides
(Falcon; BD Biosciences, Bedford, MA) treated with poly-
L-lysine, and then transfected with either WT/AVP231 or
DL-Mt/VP231. Approximately 72 hours after transfection,
the cells were washed with PBS and fixed in 4% parafor-
maldehyde in PBS for 15 minutes at room temperature.
The cells were then permeabilized with 0.5% Triton X-100
in PBS for 20 minutes at room temperature. After fixation
and permeabilization, the cells were rinsed in PBS con-
taining 0.05% Tween 20, then blocked with PBS contain-
ing 5% normal goat serum at room temperature for 30
minutes. The cells were incubated with anti-VP1BC anti-
body for 1 hour, washed in PBS containing 0.05% Tween
20, and further incubated with the secondary antibody
conjugated with Alexa Fluor 488 (Molecular Probes; Invitro-
gen). For double staining, the cells were also incubated with
anti-PML antibody followed by the secondary antibody con-
jugated with Alexa Fluor 568. After three washes in PBS,
samples weremounted in Vectashieldmedium (Vector Lab-
oratories, Burlingame, CA). Fluorescent images were cap-
tured using a TCS-SP confocal laser microscope (Leica
Microsystems, Wetzlar, Germany).
Human brain tissues affected with progressive multifo-
cal leukoencephalopathy were obtained from autopsy,
and formalin-fixed, paraffin-embedded blocks were pre-
pared with a standard protocol. Thin sections were
deparaffinized and hydrated. The sections were then
double-stained in the same manner as the cultured cells
for analysis with a TCS-SP confocal laser microscope
(Leica Microsystems).
Electron Microscopy
The cells were cultured and then transfected with either
WT/AVP231, DL-Mt/VP231, or the vector encoding onlyVP1. Approximately 72 hours after transfection, the cells
were fixed for 1 hour in 2.5% glutaraldehyde in 0.025
mol/L cacodylate buffer (pH 7.2), with careful manipula-
tion for optical electron microscopic observation. Then,
the cells were postfixed for 1 hour in 1% osmium tetroxide
in phosphate buffer. The fixed cells were dehydrated,
and embedded in epoxy resin. Ultrathin sections were
made with a diamond knife and stained with uranyl ace-
tate and lead citrate, for observation under a Hitachi
electron microscope (H-7100; Hitachi High Technolo-
gies, Tokyo, Japan).
For immunoelectron microscopy, a postembedding
method was applied. The transfected cells were fixed in
4.0% paraformaldehyde in 0.1 mol/L phosphate buffer,
pH 7.4, for 15 minutes, then dehydrated and embedded
in LR White resin. Ultrathin sections were prepared and
mounted on nickel grids. After incubation with 10% nor-
mal goat serum for 10 minutes, the sections were incu-
bated overnight at 4°C with anti-VP1HI antibody, a poly-
clonal rabbit serum raised against the synthetic peptide
corresponding to the HI loop structure of the VP1 protein
(a kind gift from K. Nagashima). After washing with PBS,
the sections were incubated with a mixture of a goat
anti-rabbit IgG conjugated to 15-nm gold particles (1:30)
for 30 minutes at room temperature. The sections were
then washed with water and stained with uranyl acetate,
and examined with a Hitachi H-7100 electron micro-
scope.
Structured Illumination Microscopy
The glass slides of human brain tissues prepared for
analysis with conventional LSCM were also used for anal-
ysis with a new super-resolution microscope, N-SIM
(Nikon, Tokyo, Japan). Resolution of conventional LSCM
was limited by diffraction to approximately 200 nm; how-
ever the SIM technology enables approximately twice the
resolution, achieved via analysis of the moiré pattern.33
Results
Eukaryotic Expression System Producing JC
Virus-Like Particles
A eukaryotic expression system to produce JC virus-like
particles (VLPs) has been established.8,34 Schematic il-
lustration of the expression vectors WT/AVP231 and
DL-Mt/VP231 (previously called AVP231-SR and VP231-
SR, respectively) is presented in Figure 1A. JC virus
Tokyo-1 has a circular double-stranded DNA genome of
5128 bp.8,35 The viral genome is divided into three parts:
the regulatory region, the early coding region, and the
late coding region. It is in the late coding region that
ORFs of the major capsid protein VP1 and the minor
capsid proteins VP2 and VP3 are located in an overlap-
ping manner, downstream of the agnogene. WT/AVP231
encodes the full-length agnogene (nt 275 to 490) and the
ORFs of VP1 and VP2/VP3; because the entire amino
acid sequence of VP3 is identical to the approximately
two thirds of the amino acid sequence of VP2, they are
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DL-Mt/VP231 encodes the ORFs of VP1 and VP2/VP3, but
the 5= terminus of the agnogene sequence (nt 275 to 409;
Figure 1. Cellular model for JC virus intranuclear inclusions. A: Polycistronic
expression vectors WT/AVP231 and DL-Mt/VP231. A model system to study
JC virus intranuclear inclusions was established. Genome fragments of JC
virus Tokyo-1 strain (wild type) were inserted into a cDNA expression vector,
resulting in WT/AVP231 and DL-Mt/VP231. WT/AVP231 encodes the agno-
protein, VP1, and VP2/VP3, whereas in DL-Mt/VP231, the 5=-sequence of the
agnogene is deleted. B: Comparison of transfection and plasmid DNA rep-
lication efficiency between cells transfected with WT/AVP231 or DL-Mt/
VP231. DNA was extracted from each type of transfected cells, serially diluted
from 1:1 to 1:1000, and then analyzed by PCR. The viral genome fragment of
the late coding region was examined, and no apparent difference was
observed between the two vectors. C: Immunoblot analysis for VP1 expres-
sion from WT/AVP231 and DL-Mt/VP231. VP1 expression was low in WT/
AVP231, but was markedly elevated in DL-Mt/VP231 with deletion of the 5=
agnogene sequence (nt 275 to 409; 135 bp). Lane 1, negative control (mock
infected cells); lane 2, WT/AVP231; lane 3, DL-Mt/VP231. D: Images from
confocal microscopy of cells transfected with WT/AVP231 or DL-Mt/VP231.
Expression of VP1 was visualized with Alexa Fluor 488 (green) and PML
protein with Alexa Fluor 568 (red). In cells transfected with WT/AVP231, VP1
is restricted to the dot-shaped PML-NBs, whereas in cells transfected with
DL-Mt/VP231 it is more diffusely distributed in the nucleoplasm, with up-
regulated expression levels. Note coarse dot-shaped VP1 expression patterns
in the nucleus of WT/AVP231 transfected cells, in contrast to the fine granular
expression patterns in the nucleus of DL-Mt/VP231 transfected cells.135 bp) is deleted.The expression vectors WT/AVP231 and DL-Mt/VP231
were transfected into COS-7 cells. To compare transfec-
tion efficiency and plasmid replication, DNA was ex-
tracted from each type of transfected cells, serially di-
luted from 1:1 to 1:1000, and then analyzed by PCR. The
PCR products were semiquantitatively compared (Figure
1B). Expression of the VP1 protein from WT/AVP231 and
DL-Mt/VP231 was also compared by immunoblotting
(Figure 1C). Despite minimal differences in transfected
plasmid DNA levels, the levels of VP1 protein differed
markedly between the two vectors. Obviously, an expres-
sion level of VP1 was low from WT/AVP231 (Figure 1C);
however, its expression was markedly increased from
DL-Mt/VP231, with the 5= termini of the agnogene se-
quence (nt 275 to 409; 135 bp) deleted (Figure 1C).
These data are consistent with our earlier study, which
compared the levels of VP1 expression by radioimmuno-
precipitation between the two vectors.8
By immunocytochemistry, it was previously demon-
strated that coexpressed VP1 and VP2/VP3 were present
in the nucleus in either cell type transfected with WT/
AVP231 or DL-Mt/VP231, regardless of the presence or
absence of the agnogene.9 Expression of the agnopro-
tein was found mainly cytoplasmic in cells transfected
with WT/AVP231.9 It was also reported that VP1-positive
cells were markedly different in number between the two
types of transfected cells; that is, the number of VP1-
positive cells was markedly large with DL-Mt/VP231
transfection, but it was small with WT/AVP231 transfec-
tion.8 This observation corresponds well with the data
from immunoblotting. Next, therefore, we used confocal
microscopy to compare intranuclear distribution of VP1
between cells transfected with WT/AVP231 and those
transfected with DL-Mt/VP231. In either type of cell, VP1
signals were frequently detected in a speckled pattern
(Figure 1D). Double-labeling analysis demonstrated that
speckled signals of VP1 were superimposed over those
of PML, suggesting preferential recruitment of VP1 to
PML-NBs. Of note, VP1 was restricted to PML-NBs in the
presence of the agnogene (WT/AVP231), but not in its
absence (DL-Mt/VP231) (Figure 1D). Thus, in cells trans-
fected with DL-Mt/VP231, VP1 immunoreactivity was ro-
bust throughout the entire nucleoplasm, whereas its
speckles were fused or amorphous. This is likely related
to elevated VP1 expression with deletion of the 5= termini
of the agnogene sequence (nt 275 to 409; 135 bp).
Ultrastructure of VLP-Harboring Cells in the
Presence or Absence of the Agnogene
This expression system is useful as a cellular model for
JC viral inclusions because major and minor capsid pro-
teins are assembled into JC virus-like particles (VLPs) in
the nucleus of transfected cells.8,9 Although VLP forma-
tion was detected in both types of cells transfected with
WT/AVP231 or DL-Mt/VP231, differences in the presence
or absence of the agnogene have not previously been
well investigated. We therefore compared ultrastructure,
to determine functions of the agnogene for JC virus mor-
phogenesis. The harvested cells were immediately fixed
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much as possible.
Even with this strong and efficient expression system,
cells harboring VLPs were few in number when cells were
transfected with WT/AVP231. Extensive searching en-
abled detection of only four VLP-positive cells by electron
microscopy; this approach had not been successful in
the previous study.8 All four VLP-harboring cells were
severely degenerated, unlike the well-preserved mor-
phology of neighboring cells lacking VLPs. It was difficult
to discern intact cell membranes. The nuclear envelopes
were also degenerated; based on the location of chro-
matin, the nuclei were found to be misshaped or col-
lapsed. Nuclear chromatin seemed dispersed and/or ir-
regularly condensed along the inner nuclear membrane
(Figure 2A).
In contrast, in cells transfected with DL-Mt/VP231, a
relatively large number of cells were found to be VLP-
positive in their nuclei. Of note, the cellular ultrastructure
was much better preserved, compared with those trans-
fected with WT/AVP231. With DL-Mt/VP231, even when
the VLPs filled the entire nucleoplasm, both the cell mem-
brane and nuclear envelope were clearly detected. In the
cytoplasm, cellular organelles were also easily recog-
nized, including mitochondria and ribosomes (Figure
2B).
Morphology of VLPs produced in cells transfected with
WT/AVP231 and of those in cells transfected with DL-Mt/
VP231 also differed. VLPs produced from WT/AVP231
were round and relatively uniform in size (40 nm) (Fig-
ure 2C). Their structures were similar to native JC virions
detected in human brain tissues from patients of progres-
sive multifocal leukoencephalopathy. In contrast, VLPs
produced from DL-Mt/VP231, in the absence of the 5=
termini of the agnogene sequence (nt 275 to 409; 135
bp), were more variable in shape and size. Even the
particles that could be classified as round were pleomor-
phic or sometimes rather polygonal, and (unlike WT/
AVP231) a large number of filamentous structures were
also observed (Figure 2D).
Immunoelectron Microscopy for Intranuclear
VP1 Distribution and VLP Formation
Next, to examine the relationship between the intranu-
clear localization of VP1 and VLP formation, the trans-
fected cells were examined by immunoelectron micros-
copy. Postembedding methods were applied in use of
the anti-VP1 antibody and colloidal gold labeling.
In cells transfected with WT/AVP231, colloidal gold
particles were frequently detected as isolated clusters
beneath the nuclear membrane (Figure 3A). This obser-
vation is consistent with the confocal microscopic imag-
ing, in which VP1 was restricted to PML-NBs, likely in
relation to well-regulated intranuclear VP1 expression
level in the presence of the agnogene (Figure 1D). Asso-
ciated with these clusters of colloidal gold, numerous
VLPs, both round and filamentous structures, were al-
ways observed (Figure 3B). These cells were similar to
glial cells containing dot-shaped inclusions in humanbrain tissues, and indicative of the early phase for viral
proliferation. Unexpectedly, however, a small number of
VP1-positive cells were also present in which colloidal
gold particles were sparsely distributed in the nucleo-
plasm without clustering beneath the nuclear membrane
(Figure 3C). In such cells, a small number of VLPs may be
observed if the density of colloidal gold particles is suf-
ficiently high (25 colloidal gold particles/m2), but usu-
ally the efficiency of VLP formation was markedly low. In
the nuclei, VLPs formed tiny clusters with local accumu-
lation of colloidal gold particles or were scattered singly
(Figure 3C).
In contrast, in cells transfected with DL-Mt/VP231, col-
Figure 2. Ultrastructure of VLPs and VLP-harboring cells. A: Ultrastructure of
WT/AVP231 transfected cells. The cells were severely degenerated, with
numerous VLPs detectable in the nucleus. Scale bar 1 m. B: Ultrastructure
of DL-Mt/VP231 transfected cells. Morphology of VLP-harboring cells was
relatively well preserved, despite extensive VLP formation in the entire area
of the nucleus. Scale bar  1 m. C: VLPs formed from WT/AVP231. Most
round VLPs were uniform in size and shape. They were markedly similar to
native JC virions observed in human glial cells. Scale bar  250 nm. D: VLPs
formed from DL-Mt/VP231. Both round and filamentous forms were seen.
Even the round VLPs were pleomorphic, variable in both shape and size.
Scale bar  250 nm.loidal gold particles were more broadly and densely dis-
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sion level with deletion of the 5= termini of the
agnogene sequence (nt 275 to 409; 135 bp). There
was a tendency for the colloidal gold particles to clus-
ter beneath the nuclear membrane; however, clusters
of the colloidal gold particles were not so isolated as
those observed with WT/AVP231 (Figure 4A). In some
cells, colloidal gold particles were seen in a band-like
distribution pattern, along the nuclear membrane (Fig-
ure 4B). Nevertheless, formation of numerous VLPs
was observed with the colloidal gold densely distrib-
uted beneath the nuclear membrane, either as clusters
or as a band-like distribution pattern. Both round and
filamentous VLP forms were seen. Furthermore, some
cells lacked dense colloidal gold distribution beneath
the nuclear membrane; instead, colloidal gold particles
were scattered sparsely in the entire nucleoplasm (Fig-
ure 4C). In these cells, similarly to those transfected
Figure 3. Immunoelectron microscopy of WT/AVP231 transfected cells. A:
Isolated clusters of colloidal gold particles labeling VP1 were present beneath
the inner nuclear membrane in cells transfected with WT/AVP231. Numerous
VLPs were observed, always associated with clusters of colloidal gold parti-
cles. Scale bar  500 nm. B: High-power view of the same cells as in A. VLPs
formed from WT/AVP231 appeared as both round particles and filamentous
forms. Colloidal gold labeling viral capsid protein VP1 is clearly present on
the surface of virus-like structures. Scale bar 250 nm. C: VLP formation was
observed, even in cells in which colloidal gold particles were distributed
diffusely in the nucleoplasm. A small cluster of VLPs may be observed with
focal accumulation of colloidal gold particles (thick arrow), or an isolated
VLP may be scattered (thin arrows). Scale bar  250 nm.with WT/AVP231, a small number of VLPs were ob-served as tiny clusters, or scattered singly, but VLP
formation was not efficient (Figure 4C).
The Agnogene Suppresses Ectopic VLP
Formation Outside of PML-NBs
Intranuclear VP1 distribution and VLP formation were sta-
tistically analyzed in greater detail (Figure 5). Because
most isolated clusters of colloidal gold were approxi-
mately 0.5 m in diameter, the numbers of clustered
Figure 4. Immunoelectron microscopy of DL-Mt/VP231 transfected cells. A:
Colloidal gold particles labeling VP1 are broadly clustered beneath the inner
nuclear membrane. Numerous VLPs of both round and filamentous structure
are also seen. Scale bar  500 nm. B: Increased expression of VP1 from
DL-Mt/VP231 resulted in a change of the distribution patterns of colloidal
gold-labeled VP1 to a band-like region beneath the inner nuclear membrane.
Scale bar  500 nm. C: Some cells show a diffuse distribution of colloidal
gold particles throughout the nucleus; however, VLPs in round or filamen-
tous form were seen as tiny clusters (arrows). Scale bar  500 nm.
ber of V
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squares, and the results were compared with those for
1.0-m square expanded regions. The paired data were
obtained from eight different areas of four different cells.
Both the areas beneath the nuclear membrane (Figure
5A) and the areas in the nucleoplasm (Figure 5B) were
comparatively examined.
Beneath the nuclear membrane (Figure 5C), the aver-
age number of clustered colloidal gold in the 0.5-m
square areas was greater with WT/AVP231 (88.83 
11.77) than with DL-Mt/VP231 (59.20  21.16), suggest-
ing concentrated VP1 accumulation around PML-NBs in
the presence of agnogene. In contrast, in the 1.0-m
square areas, the total number of colloidal gold was
greater with DL-Mt/VP231 (192.80  52.65) than WT/
AVP231 (161.67  29.99), reflecting the elevated VP1
expression with deletion of the 5= sequence of the agno-
gene. In both types of cells transfected with either WT/
Figure 5. Quantitative analysis of intranuclear distribution of VP1 and VL
statistical analysis. The number of colloidal gold and VLPs were counted in
1.0 m square (n  8). A: Examples for the two areas beneath the nuclear
for the two areas in the nucleoplasm, where colloidal gold particles were sp
beneath the nuclear membrane for WT/AVP231 and DL-Mt/VP231. *P  0.05
the nucleoplasm. Colloidal gold particles were sparsely distributed; the num
those with DL-Mt/VP231.AVP231 or DL-Mt/VP231, a sufficient number of VLPswere detected in the 0.5-m squares beneath the mem-
brane, suggesting efficient VLP formation at PML-NBs.
No significant difference could be seen for the VLP num-
ber in the 0.5-m squares between cells transfected with
WT/AVP231 (46.17  7.60) and those transfected with
DL-Mt/VP231 (53.80  4.38). In the 1.0-m squares,
however, a greater number of VLPs was observed in
cells transfected with DL-Mt/VP231 (79.00  15.13)
than in those transfected with WT/AVP231 (178.20 
19.15), and the difference was significant (P  0.05,
Mann-Whitney test).
In the nucleoplasm (Figure 5D), even when colloidal
gold was distributed sparsely, VLP formation was de-
tected in both types of cells, when density of colloidal
gold was sufficient (25 colloidal gold particles/m2).
Both density of colloidal gold and efficiency of VLP for-
mation were relatively higher in cells transfected with
DL-Mt/VP231 than in those transfected with WT/AVP231,
tion. The data of electron micrograph were examined quantitatively with
5 m square (n  8), and the results were compared with expanded areas
ne, where colloidal gold particles were densely accumulated. B: Examples
istributed. C: Number of colloidal gold particles and VLPs in the two areas
Whitney test. D: Number of colloidal gold particles and VLPs in the areas of
LPs was also low in both cell types, those transfected with WT/AVP231 andP forma
areas 0.
membra
arsely d
, Mann-reflecting elevated intranuclear VP1 expression levels
ity, as 
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ciency of VLP formation, however, was markedly low.
The results of immunoelectron microscopy are summa-
rized in Table 1. Among 30 VP1-positive cells for WT/
AVP231, 10 cells showed dense colloidal gold distribu-
tion beneath the nuclear membrane, and VLP formation
was observed in all of the cells (100%). Similar results
were obtained in the case of DL-Mt/VP231 (25 VP1-pos-
itive cells were examined). However, even in cells in
which colloidal gold particles were scattered in the nu-
cleoplasm, a small number of VLPs were also seen ran-
domly in the nucleus, if density of colloidal gold particles
was sufficient (ie, 25 colloidal gold particles/m2)
(100%). When colloidal gold density was low (ie, 25
colloidal gold particles/m2), however, VLP assembly
was not detected in either type of cells transfected with
WT/AVP231 or DL-Mt/VP231 (0%). In addition, VP1 alone
was expressed, without VP2 and VP3. However, VP1 was
dispersed both in the cytoplasm and the nucleus, and
VLPs were not detected in any of the 25 cells examined
(0%; data not shown). Even in the presence of agnopro-
tein, VP1 alone was not accumulated to the nucleus with-
out VP2 and VP3, as described previously.8,9
Taken together, VLP formation itself can proceed out-
side of PML-NBs, if the density of the capsid proteins is
sufficiently high for protein-protein interaction. With dele-
tion of the 5= termini of the agnogene sequence, VLPs
may be more randomly formed in the nucleus, likely be-
cause of elevated VP1 expression. However, VLPs gen-
erated outside PML-NBs seem pleomorphic and low in
pathogenicity. Therefore, the agnogene (or its product)
regulates intranuclear expression levels of the capsid
proteins and enables their restricted accumulation to
PML-NBs, which is important for efficient production of
pathogenic viruses.
Table 1. Intranuclear Localization of VP1 Capsid Protein and As
No. of cells
Beneath nuclea
dots or b
WT/AVP231 n30 100 (1
DL-MT/VP231 n25 100 (1
VP1 alone n25 0 (0
High density is defined as 25 colloidal gold particles/m; low densJC Progeny Virions Are Likely Produced on the
Surface of PML Spherical Shells
Intranuclear localization of JC virus VP1 capsid protein
was further analyzed in naturally infected oligodendro-
glia, obtained from autopsied brain tissues from patients
with progressive multifocal leukoencephalopathy. By
conventional LSCM, the x-y sectional images revealed
that VP1 was localized to PML-NBs, which appeared as a
punctuate structure frequently located beneath the nu-
clear membrane (Figure 6). Usually, in JC virus-infected
human glial cells, PML-NBs were larger in size but fewer
in number, compared with those in transfected COS-7
cells producing VLPs. Approximately three to seven PML-
NBs, of different sizes, were observed in the enlarged
nuclei of JC virus-infected glial cells. In the optimal x-y
sections, some of the largest PML-NBs were approxi-
mately 1 m in diameter and displayed notably reduced
PML fluorescence signals in the center of the spheres. A
series of sections along the z axis demonstrated that the
three-dimensional organization of PML-NBs is regular
spherical shells.
To further observe precise VP1 localization and
PML-NB structures in the oligodendroglia with natural JC
virus infection, a novel structured illumination microscope
was applied. Images at twice higher resolution were ob-
tained with improvement of the diffraction limit below the
200 nm of conventional LSCM. Intensity of the PML sig-
nals was higher at the outer shell of large PML-NBs and
lower inside, leading to visualization of PML-NBs as a
spherical shell in three-dimensional presentation and as
a ring-like structure in two dimensions (Figure 7A). The
viral capsid protein VP1 appeared to be more densely
located on the outer part of the PML spherical shells. To
of Virus-Like Particles
s-like particle formation [% (no. of cells)]
brane In nucleoplasm,
high density
In nucleoplasm,
low density
100 (5) 0 (15)
100 (10) 0 (5)
0 (25)
25 colloidal gold particles/m.
Figure 6. Conventional LSCM images of JC vi-
rus-infected human glial cells. In human brain
tissue, JC virus-infected glial cells frequently dis-
play intranuclear inclusions in dots (dot-shaped
inclusions), which are usually located beneath
the inner nuclear membrane. These inclusions
reflect localization of JC viral proteins to PML-
NBs. JC virus VP1 protein was visualized with
Alexa Fluor 488 (green) and PML protein with
Alexa Fluor 568 (red); the merged image indi-
cates VP1 localization to PML-NBs. Usually some
five to eight dot-shaped inclusions, differing in
size, are seen in the enlarged nuclei of infected
cells. The largest PML-NBs displayed a ring-like
structure in the optimal x-y section by conven-
tional LSCM.sembly
Viru
r mem
ands
0)
0)
)
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averaged correlation of pixel intensities was computed
from the image. The resulting curves of both VP1 and
PML signals yielded two peaks, and distance of the two
VP1 peaks, 1.2 m, was slightly larger than that of the two
PML peaks, 1.0 m (Figure 7B). The spherical shell of the
PML protein has a thickness of approximately 300 to 400
nm. The data indicate that the VP1 protein is densely
localized to the surface regions of PML spherical shells,
and that progeny viruses may be actively proliferating in
these locations.
Finally, oligodendroglia with natural viral infection, ob-
tained from autopsied human brain tissue, were reviewed
by electron microscopy, to see if a ring-like alignment of
progeny virions is present beneath the nuclear mem-
brane (Figure 8). Ring-like structures of high electron
density were observed, approximately 700 nm in diame-
ter and 300 to 400 nm in thickness. Progeny virions of a
uniform round shape were seen around the structures,
consistent with the progeny production on the surface of
PML spherical shells.
Discussion
A new pathological hallmark of JC virus infection, namely,
dot-shaped nuclear inclusions, represents viral accumu-
lation to the PML-NBs, which provide scaffolds for JC
virus proliferation.6,7 In the present study, we investi-
gated pathological roles of PML-NBs in JC virus infection
in a cellular model and in human brain tissue. With anal-
ysis of a cellular model producing VLPs, functions of the
agnogene were analyzed for intranuclear distribution of
VP1 and VLP formation at PML-NBs (Figures 1–5). The
importance of PML-NBs as the sites for pathogenic viralprogeny production was confirmed in oligodendroglia
with natural JC virus infection obtained from autopsied
human brain tissue (Figures 6–8).
An efficient expression system of JC virus capsid pro-
teins was established, and this system enabled electron
microscopic analysis of VLP-harboring cells. JC virus
replicates slowly in cell culture systems. Primary human
fetal glial (PHFG) cells were first found to support the viral
replication, but JC virus late RNAs were not detected until
10 days after infection.36 Given the difficulty of obtaining
PHFG cells, the cells were transformed with either SV40
or JC virus T antigen, resulting in SVG37 and POJ cells,38
respectively. Other useful systems include primary hu-
Figure 7. SIM images of PML-NBs in JC virus-
infected human glial cells. A: Precise PML-NB
organization was examined by SIM in JC virus-
infected human glial cells. JC virus VP1 was vi-
sualized with Alexa Fluor 488 (green) and PML
protein with Alexa Fluor 568 (red). The largest
PML-NBs displayed a ring-like structure in the
optimal x-y section, which was found to be
formed in spherical shells in three dimensions.
VP1 protein was surrounding the outer surface
of the PML-NB spherical shells. Arrows span the
diameter of the ring-like structure. B: Relative lo-
calization of JC virus VP1 to PML-NBs. Image in-
tensity profiles were taken along the diameters
indicated by arrows in panel A, and the pixel
intensities were computed. The red curve repre-
sents the PML signal, and the green curve, VP1.
Both PML and VP1 curves displayed two peaks,
but the peak distance of VP1 (1.2 m) was
slightly longer than that of the PML protein (1.0
m). The PML-NB spherical shell was deter-
mined to be 300 to 400 nm thick.
Figure 8. Electron micrographs of JC-infected glial cells in the human brain
tissue. Beneath the inner nuclear membrane, a ring-like structure of high
electron density was present (700 nm in diameter and 300 to 400 nm in
thickness, as indicated by nested circles in the left panel). Progeny virions
as round structures were detected around the ring-like structures (compare
the region indicated by nested circles in the left panel with the corre-
sponding region the right panel). There were several clusters of high
electron density, 700 nm to 1 m in diameter, aligned beneath the inner
nuclear membrane (arrows in the right panel). Scale bar  1.0 .
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man glioblastoma cell line U-87MG.40 In addition to neu-
ral cells, COS-7 cells (monkey kidney cells constitutively
expressing SV40 T antigen) were also found to support
JC virus proliferation,41 with efficiency much higher than
that of human brain progenitor-derived astrocytes
(PDA).42 Unlike SV40, however, which causes cell death
24 hours after infection, JC virus is slow to replicate, a
characteristic that hampers study of JC virus capsid pro-
teins. The JC virus capsid proteins were therefore ex-
pressed under the powerful SR promoter, and analysis
of VLP formation was performed at 72 hours after trans-
fection. The relatively well-preserved morphology of VLP-
harboring cells also enabled electron microscopic anal-
ysis with colloidal gold labeling of VP1.
Electron microscopy of VLP-harboring cells indicated
that the agnogene regulates intranuclear expression level
of VP1 and its restricted PML-NB accumulation for effi-
cient VLP formation (Figures 1–4). Functions of the ag-
nogene and its product, agnoprotein, have been argued
for years. For example, it has been reported that the
leader sequence including the agnogene contains a cis-
acting DNA element to which transcription factors may
bind, and agnoprotein itself also modulates viral gene
transcription associated with a cellular transcription fac-
tor, such as YB-1.43,44 Translation of the capsid proteins
is likely suppressed because of the presence of the AUG
start codon of the agnogene on the polycistronic viral
mRNAs.8 The agnoprotein also affects nuclear transport
of the capsid protein, viral assembly possibly, in part, by
altering conformation of VP1, and progeny release from
the host cells.8,9,45 Moreover, the agnoprotein directly
acts on the host cells, inhibiting DNA repair and DNA
damage-induced cell cycle regulation.46,47 The agnopro-
tein also suppresses cell cycle progression by interacting
with p53,48 and promotes apoptosis.49 After longstand-
ing argument, however, it is now generally considered
and expected that the agnogene and its product have
multiple regulatory roles, but in total promote viral prog-
eny proliferation and host cell degeneration. Our results
are consistent with this idea.
PML-NBs are targets of JC virus infection. Our current
hypothesis is that viral genomic DNA replication and cap-
sid assembly may simultaneously proceed at PML-NBs,
and that the agnogene and its product facilitate these
processes. In support of this idea, a recent publication
concerning JC virus mutant study reported that agnopro-
tein-negative mutant viruses are mostly deficient in DNA
content,50 and similar results were also described in BK
virus that agnoprotein-deletion mutant failed to produce
infectious progeny despite formation of nuclear virus-like
particles.51 Indeed, JC virus-infected human glial cells
are in an S-phase-like state, with expression of prolifer-
ating cell nuclear antigen (PCNA),7 which would be ad-
vantageous for the viral genomic DNA replication. More-
over, JC viral large T antigen, an early regulatory protein
essential for viral DNA replication, was also detected at
PML-NBs in JC virus-infected cultured cells,52 suggest-
ing JC viral DNA replication at PML-NBs. Thus, viral as-
sembly at PML-NBs would be important for pathogenic
progeny production containing the viral genomic DNA,and the agnogene and its product would positively reg-
ulate total viral progeny proliferation at PML-NBs. Recent
publications have also described JC virus replication in
various types of neuronal cells, causing neuronopa-
thy.53–57 Functions of PML-NBs in nondividing neurons
are also worthy of study.
As another novel finding, dot-shaped JC virus inclu-
sions in human brain tissue were shown to have a shape
of spherical shells (Figures 6–8). Structured illumination
microscope (SIM),33 a new technology, enabled twice
higher resolution than conventional LCSM. Precise VP1
localization was revealed on the largest PML-NBs of
spherical shells, which were 1.0 m in diameter with a
thickness of 300 to 400 nm (Figure 7). This organization of
PML-NBs is, in part, similar to those in U2OS and HeLa
cell lines, which were analyzed with high-resolution 4Pi
fluorescence laser scanning microscopy.12 In these cell
lines, PML-NBs appeared as spherical shells composed
of PML and Sp100 proteins, with a diameter between 0.3
and 1.0 m. Irrespective of PML-NB diameter, the thick-
ness of spherical shells was found to be 50 to 100 nm. In
JC virus-infected human glial cells, however, the largest
PML spherical shells were 300 to 400 nm thick, which is
about three to four times greater than the thickness ob-
served in U2OS and HeLa cell lines (50 to 100 nm). It is
not known how a variety of component proteins that con-
sistently or transiently reside in PML-NBs cooperate to
exert different biological activities. It has been thought
that the spherical shell structure might discriminate inter-
nal and external domains, and disturb interaction of mul-
tiple PML-NB components.12 However, our data first in-
dicate the importance of the PML-NB surface as an active
site for nuclear functions, with JC virus actively prolifer-
ating progenies at the surface regions of thick PML
spherical shells.
In conclusion, specific intranuclear locations for JC
virus proliferation exist, and these locations are PML-
NBs. PML-NBs organize spherical shells in JC-virus in-
fected human glial cells, and the virus likely proliferates at
their surface regions. This intranuclear location seems
important for production of pathogenic progeny, contain-
ing a viral genomic DNA and leading to subsequent
degeneration of host cells.
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